Academic Journal
Q3Hemato
About Hemato
Hemato is a scholarly journal published by Multidisciplinary Digital Publishing Institute (MDPI). SCImago 2025 lists it in Q3, with an SJR of 0.292 and H-index of 10.
Coverage: 2020-2025. Research categories: Hematology (Q3).
Verified field sources
- Journal Impact Factor: 0.7 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from the publisher imprint.
- Impact Factor year: 2025 — Official source; checked 2026-10-03. Journal Impact Factor and reporting year from the publisher imprint.
- Contact email: hemato@mdpi.com — Official source; checked 2026-10-03. Journal editorial office email published by MDPI; manuscript files use the submission system.
- Editor(s): Prof. Dr. Antonino Carbone (Editor-in-Chief) — Official source; checked 2026-10-03. Current chief editor(s) listed on the official MDPI editorial board. Founding and section editors excluded.
Open-access policies and author information
Reported in the official DOAJ public CSV snapshot (2026-09-01), downloaded 2026-10-03. Record updated 2023-04-12. This snapshot does not establish today’s listing status or fee quotation.
Publisher policy links recorded by DOAJ
- Aims and scope ↗
- Editorial board ↗
- Instructions for authors ↗
- Peer-review policy ↗
- Publication fees ↗
- Fee waivers ↗
- Licence terms ↗
- Copyright policy ↗
- Preservation policy ↗
Source: DOAJ journal record. Journal metadata is distributed by DOAJ under CC0. Confirm current fees, tax, eligibility and waiver terms with the publisher.
Source-backed journal facts
Topics in published research
Lymphoma Diagnosis and Treatment; Chronic Lymphocytic Leukemia Research; Acute Myeloid Leukemia Research; Multiple Myeloma Research and Treatments; Chronic Myeloid Leukemia Treatments; Myeloproliferative Neoplasms: Diagnosis and Treatment.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
Global Research Trends in Primary Plasma Cell Leukemia: A Bibliometric Analysis
Öznur Aydın, Serkan Güven
2026-10-01 · DOI: 10.3390/hemato7040034From Disease Control to Precision Care: The Enduring Legacy of Michele Baccarani in Chronic Myeloid Leukemia
Francesco Onida
2026-09-29 · DOI: 10.3390/hemato7040033Cross-Reactivity and Drug Rechallenge in Idiosyncratic Drug-Induced Severe Neutropenia and Agranulocytosis
Emmanuel Andrès, Xavier Jannot, Jean-Edouard Terrade, Noel Lorenzo-Villalba et al.
2026-09-28 · DOI: 10.3390/hemato7040032Prolidase Deficiency Presenting with Hyperferritinemia, Splenomegaly and Cytopenia, Later Complicated by Thrombotic Thrombocytopenic Purpura
Giacomo Marchi, Fabio Chesini, Nicola Martinelli, Misha Fatima et al.
2026-09-22 · DOI: 10.3390/hemato7040031Acute Myeloid Leukemia in Older Adults: A Comprehensive Narrative Review of Risk Stratification and Treatment Advances
Ahmed S. Mohamed, Shraboni Dey, Shibhani Rajanna, Marina Basta et al.
2026-09-01 · DOI: 10.3390/hemato7030030Emperipolesis of Erythroid Cells in Acute Myeloid Leukaemia with Myelodysplasia-Related Changes: A Case Report and Literature Review
Bingwen Eugene Fan, Dheepa Christopher, Kian Guan Eric Lim, Yu Han Koh et al.
2026-08-24 · DOI: 10.3390/hemato7030029Pharmacogenetic Profiling of Allogeneic Stem Cell Transplantation Patients: An Exploratory Descriptive Study
Lea P. A. Timmann, Pauline Lanting, Linde M. Morsink, Marcel Nijland et al.
2026-08-21 · DOI: 10.3390/hemato7030028Real-World Survival Outcomes of Hypomethylating Agents and Allogeneic Hematopoietic Stem Cell Transplantation in Myelodysplastic Syndromes: A Retrospective Single-Center Experience
Kamil Deveci, Esra Yildizhan, Ali Unal
2026-08-13 · DOI: 10.3390/hemato7030027C-Reactive Protein-to-Albumin Ratio and Its Association with Inflammatory and Renal Parameters in Multiple Myeloma
Asli Odabasi Giden
2026-08-05 · DOI: 10.3390/hemato7030026Complex Karyotype and TP53 Alterations in AML and MDS
Ugo Testa
2026-08-03 · DOI: 10.3390/hemato7030025Assessment of Nutritional Status in Adult Patients with Acute Myeloid Leukemia: The Role of Screening Tools, Composite Indices, Body Composition, and Physical Function—A Structured Narrative Review
Dariusz Łętowski, Martyna Bednarczyk, Konrad Matlak
2026-07-29 · DOI: 10.3390/hemato7030024Auto Transfusion-Can It Be Used as an Alternative to Pre-Hospital Fresh Blood in Severe Shock Where Blood Is Not Available?
Noam Gavriely, Gil Hirschhorn, Joseph Marfori, Efrat Gavriely et al.
2026-07-10 · DOI: 10.3390/hemato7030023Flow Cytometry Immunophenotyping in Hematology Clinical Practice: Panacea or a Diagnostic Tool? Conclusions from a Case Report
Georgios Boutsikas, Konstantinos Agiannitopoulos, Ioannis Anagnostopoulos, Myrofora Vikentiou et al.
2026-06-22 · DOI: 10.3390/hemato7020022Acute Myeloid Leukemia Following Mantle Cell Lymphoma: Clonal Evolution Versus Therapy-Related Pathogenesis—A Case Report with Longitudinal Molecular Tracking
Ahmed S. Mohamed, Marina Basta, Shibhani Rajanna, Maggie James et al.
2026-06-08 · DOI: 10.3390/hemato7020021Redefining Caregiver and Patient Resilience in Hematologic Malignancies: A Narrative Review
Valentina Zoboli, Stefano Botti, Daniela Manzo, Federica Olivazzi et al.
2026-06-01 · DOI: 10.3390/hemato7020020Primary Myelofibrosis vs. Multiple Myeloma-Associated Bone Marrow Fibrosis: When Treatment Response Clarifies the Diagnosis
Dolly Viviana Fiallo-Suárez, Ruth Stuckey, Angelina Lemes-Castellano, Alexia Suárez-Cabrera et al.
2026-05-30 · DOI: 10.3390/hemato7020019Age-Associated Changes in Mean Corpuscular Volume and Leukocyte Ratios in U.S. Adults
Yihan Wang, Yijun Pan, Sapha Shibeeb
2026-05-25 · DOI: 10.3390/hemato7020018Second Primary Malignancies After Primary Gastric Lymphoma: Incidence, Risk Factors, and Clinical Implications
Fanny Erika Palumbo, Calogero Vetro, Lucia Gozzo, Davide Giuseppe Castiglione et al.
2026-05-22 · DOI: 10.3390/hemato7020017Real-World Outcomes of Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia
Asli Odabasi Giden, Duzgun Ozatli, Mehmet Ali Erkurt, Abdullah Karakus et al.
2026-05-15 · DOI: 10.3390/hemato7020016Blastic Plasmacytoid Dendritic Cell Neoplasm in the Era of Targeted Therapies
Ugo Testa
2026-05-14 · DOI: 10.3390/hemato7020015Reviews
Community Reviews
Version History
October 4, 2026 at 9:30 pm
October 2, 2026